← Scoopfeeds — Intelligent news, curated.
Evercore ISI raises BridgeBio Pharma price target on Attruby sales
business

Evercore ISI raises BridgeBio Pharma price target on Attruby sales

Investing.com · May 8, 2026, 9:53 AM · Also reported by 4 other sources

Evercore ISI raises BridgeBio Pharma price target on Attruby sales

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Rosenblatt resets Palantir stock price target after earnings Yahoo Finance The Middleby Sees Strong Q1 Sales, Raises 2026 Outlook The Verge Sony’s PS5 sales plummet amid price rises and a memory crisis Bloomberg Markets Novo Nordisk’s Ozempic India Price Cut Boosts Obesity Drug Sales

More in business

CoinDesk
Coinbase blames AWS for hours-long crypto trading outage
CNBC
A cloud computing stock is soaring more than 25%. Here’s what’s driving the rally
Investing.com
RBC Capital raises Affirm stock price target on margin strength
Investing.com
KeyBanc lowers McDonald’s stock price target to $330 on model adjustments
Investing.com
Needham raises JFrog stock price target to $80 on cloud growth
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop